Kidney and heart prevention program after preeclampsia
Official title: Pilotprojekt Renale Und kardiovaskuläre Tertiärprävention Nach Präeklampsie
Run by University Hospital Schleswig-Holstein · NCT07151339 · Data updated 2026-11-12
This program will see if follow-up care plus a biobank can help identify and manage long-term kidney and heart risks for women who had preeclampsia, HELLP, eclampsia, or pregnancy-related kidney disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 100 (estimated) |
| Sponsor | University Hospital Schleswig-Holstein Academic / other |
| Locations | 1 site (Kiel) |
| Status | Recruiting |
| Started | November 1, 2024 |
| Main results expected | November 2029 |
| Study ends | November 2030 |
| Registry record updated | September 3, 2025 |
| Trial ID | NCT07151339 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult women (over 18) with a diagnosis of preeclampsia, HELLP syndrome, eclampsia, or pregnancy-related kidney disease are the intended participants.
✕Probably not a fit
Those unable to provide informed consent and people without pregnancy-related hypertensive or kidney conditions are unlikely to receive direct benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational program enrolls adult women diagnosed with preeclampsia, HELLP syndrome, eclampsia, or pregnancy-associated kidney disease and follows them after pregnancy. Participants receive guideline-based clinical follow-up while investigators collect medical data and biological samples to create a biobank. No experimental treatments are provided and care follows national and international recommendations. The collected data and samples will be used to better understand long-term renal and cardiovascular risks and to inform future prevention efforts.
Why it matters
Potential benefit: If successful, the program could help identify patients at higher risk of future kidney or heart problems and improve follow-up care and prevention strategies.
How similar studies have gone: Previous cohort and biobank efforts have documented links between preeclampsia and later cardiovascular and renal disease, so this approach builds on existing observational evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * older than 18 yrs * diagnosed preeclampsia, HELLP syndrome or kidney disease durig pregnancy Exclusion Criteria: * unable for informed consent
Where it's running
-
University Hospital Schleswig- Holstein
Kiel, Germany Recruiting
Study contacts
- Study coordinator: Laura K Sievers, MD
- Email: Laura.Rakow@uksh.de
- Phone: +49 431 500 23001
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Community health worker support to lower blood pressure after pregnancy with high blood pressure
Postpartum patients with high blood pressure after pregnancy will try a program where a trained community health worker helps them monitor blood pressure and manage care for 6 months to see if it lowers blood pressure compared with usual care.
-
Registry for women with preeclampsia and related conditions
This study is collecting health information from women with preeclampsia and related conditions to help researchers learn more about the causes and find better treatments for this serious pregnancy issue.
-
Preeclampsia Biomarker Test in African Women
This study tests whether measuring the sFlt-1/PlGF ratio using quick clinic tests helps predict which pregnant women in Africa will develop severe preeclampsia.
-
Predicting Adverse Pregnancy Outcomes in Uganda through Partnerships and Innovation
This study tests whether everyday health data, ultrasound, and blood samples from first-time pregnant women in Uganda can help predict problems like preeclampsia, fetal growth restriction, and preterm birth.
-
Internal jugular vein collapsibility to gauge volume status in preeclampsia vs. normal pregnancy
This study tests whether ultrasound of the internal jugular vein can show differences in fluid status between preeclamptic pregnant people and those with normal blood pressure during planned cesarean delivery.
-
Higher vs lower daily aspirin in high-risk pregnant people
This study tests whether taking 150 mg of aspirin daily is more effective than 75 mg daily in preventing preeclampsia among pregnant people at high risk.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.